Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

“Each person responds differently to medications, and the degree of weight loss achieved with treatment can vary based on ...

Adults With Obesity More Likely to Ration Drugs to Save Money. Adults with obesity are more likely to ration their ...

The use of weight loss drugs without doctor's supervision is not advisable and can lead to serious side effects and ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

The current pain caused by the high cost of the GLP-1 agonist anti-obesity drugs will pass. Prachi Patkee and other analysts ...

SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...